Medical Eligibility Required Semaglutide and Tirzepatide cannot be prescribed to individuals with the following conditions: BMI under 27, eating disorders, Type 1 diabetes, gallbladder disease, substance abuse, recent bariatric surgery (within the past 6 months), pancreatitis or history of recurrent pancreatitis while taking a GLP-1 medication, medullary thyroid cancer, current pregnancy or breastfeeding, plans to become pregnant, diabetic retinopathy, multiple endocrine neoplasia type 2 (MEN2) or family history of MEN2, serious gastrointestinal disorders, or history of allergic reaction to Tirzepatide or Semaglutide
Deputy Editor Paul Kita, and Charles Thorp, NASM Fitness and Commerce Editor to get their insights on the electrolyte products they have tested throughout their years in the industry
Both are peptide programs with no public efficacy readouts
If youre using hormonal birth control and it is depleting your ability to protect your cells then you can expect cell damage
This can be particularly beneficial for individuals with digestive issues, chronic stress, fatigue, or increased nutritional demands
Where Akkermansia Fits into the GLP-1 Ecosystem 1